Loading...
OTC Markets
Totals
Securities
11,064
Dollar Vol
$2.3B
Share Vol
3.7B
Trades
396,945

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

VDRM
ViaDerma, Inc.

Common Stock
OTC Disclosure & News Service

LOS ANGELES, March 08, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), is pleased to provide an update of the Company’s current marketing activities:

  • ViaDerma is in discussions with a Huntington Beach based international consulting firm, to explore placement of Vitastem in Infomercials, a nationwide pharmacy chain with 9600 stores domestically, and foreign placements throughout the Middle-East and Dubai.
  • Discussions are also ongoing with representatives from a nationwide pharmaceutical distributor regarding distribution of Vitastem through their affiliated pharmacies and hospitals throughout the US, as well as distribution in the veterinary market though their association with veterinary suppliers nationwide.
  • ViaDerma is awaiting a formal proposal from CMD Innovations, LLC, to use Vitastem in their wound healing protocol. CMD provides effective medical solutions for healthcare facilities including V.A. Hospitals.
  • Negotiations are ongoing with a large, regional medical supply sales force for product distribution in pharmacies throughout the Southern United States.
  • Vitastem is currently undergoing an approval process by government regulatory agencies in Nigeria and the Philippines. Upon approval, Vitastem will be distributed to hospitals in those countries and the Philippines prison system.
  • Begun the process for approval of Vitastem by Medicare and other insurance companies reimbursement.
  • ViaDerma’s technology is currently being used in Elixr Cannabis products; Topical Balm, Topical Serum and Topical Spray. Sales have begun in Canada.
  • Last month ViaDerma was a proud sponsor at “SB52 Big Game Event” held during Superbowl weekend in Minneapolis, organized by The Brewer Group, a marketing, media and consulting firm founded by former NFL player, Jack Brewer.                                                                                                                                    

Dr. Christopher Otiko, President of ViaDerma, stated, “We are very excited in the direction we are headed with our product distribution efforts. We will provide further updates to these and other initiatives as developments unfold.”

About ViaDerma, Inc.
ViaDerma, Inc. (OTC:VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. For more information, visit: www.viadermalicensing.com

Any forecast of future performance is a "forward looking statement" under securities laws. Such statements are included to allow potential investors the opportunity to understand management’s beliefs and opinions with respect to the future so that they may use such beliefs and opinions as one factor among many in evaluating an investment.

Contact information:
Investor Relations
Email:  info@viadermalicensing.com
Phone: 310-374-6111

Expert Market Icon
This market serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing.
Expert Market
OTC Markets Group is unable to confirm this company is providing public disclosure to a regulator, an exchange, or OTC Markets Group.
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.